BIOMAT Database Logo BIOMAT Database Logo

Biological changes in serum antiproteases as related to tumor progression. 1988

J Millán, and A Senra, and A Lorenzo, and J Romero, and P Rodriguez, and P Gallurt
Department of Internal Medicine, Faculty of Medicine, University of Cádiz, Spain.

The two major antiproteases (alpha-1-antitrypsin and alpha-2-macroglobulin) were studied in the serum of cancer patients (273 and 103 subjects, respectively) and in a control group. In cancer patients, the values were stratified by clinical stage (local, loco-regional and metastatic disease). Serum alpha-1-antitrypsin was different in normal people (341 +/- 110.7 mg/dl) than in every cancer group (p less than 0.0005). The behavior of alpha-2-macroglobulin was similar, with significant differences (p less than 0.0005) between normal people (317.6 +/- 105.4 mg/dl) and the cancer groups. Serum alpha-1-antitrypsin was different in local, loco-regional and metastatic disease; however, alpha-2-macroglobulin did not show these differences. In metastatic disease, sensitivity was 96.66% for alpha-1-antitrypsin and 94.79% for alpha-2-macroglobulin.

UI MeSH Term Description Entries
D008297 Male Males
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000511 alpha-Macroglobulins Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters. Slow alpha 2-Macroglobulins,alpha 2-Acute Phase Globulins,alpha-Macrofetoproteins,45S RNP,Acute-Phase alpha 1-Protein,Slow alpha 2-Globulin,alpha 1-Acute Phase Globulin,alpha 1-Acute Phase Protein,alpha 1-Macroglobulin,alpha 2-Acute Phase Globulin,alpha-Macrofetoprotein,Acute Phase alpha 1 Protein,RNP, 45S,Slow alpha 2 Globulin,Slow alpha 2 Macroglobulins,alpha 1 Acute Phase Globulin,alpha 1 Acute Phase Protein,alpha 1 Macroglobulin,alpha 1-Protein, Acute-Phase,alpha 2 Acute Phase Globulin,alpha 2 Acute Phase Globulins,alpha 2-Globulin, Slow,alpha 2-Macroglobulins, Slow,alpha Macrofetoprotein,alpha Macrofetoproteins,alpha Macroglobulins
D000515 alpha 1-Antitrypsin Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Trypsin Inhibitor, alpha 1-Antitrypsin,alpha 1-Protease Inhibitor,alpha 1-Proteinase Inhibitor,A1PI,Prolastin,Serpin A1,Zemaira,alpha 1 Antiprotease,alpha 1-Antiproteinase,1-Antiproteinase, alpha,Antiprotease, alpha 1,Inhibitor, alpha 1-Protease,Inhibitor, alpha 1-Proteinase,Trypsin Inhibitor, alpha 1 Antitrypsin,alpha 1 Antiproteinase,alpha 1 Antitrypsin,alpha 1 Protease Inhibitor,alpha 1 Proteinase Inhibitor

Related Publications

J Millán, and A Senra, and A Lorenzo, and J Romero, and P Rodriguez, and P Gallurt
Hypercoagulability, hyperlipidemia, and serum antiproteases.
May 1985, Annals of internal medicine,
J Millán, and A Senra, and A Lorenzo, and J Romero, and P Rodriguez, and P Gallurt
Serum antiproteases in normal pregnancy; a comparison with changes observed in neoplastic disease.
February 1951, Surgery, gynecology & obstetrics,
J Millán, and A Senra, and A Lorenzo, and J Romero, and P Rodriguez, and P Gallurt
Serum alarm antiproteases in systemic sclerosis patients.
September 2017, Human immunology,
J Millán, and A Senra, and A Lorenzo, and J Romero, and P Rodriguez, and P Gallurt
Antiproteases as therapeutics to target inflammation in cystic fibrosis.
March 2010, The open respiratory medicine journal,
J Millán, and A Senra, and A Lorenzo, and J Romero, and P Rodriguez, and P Gallurt
Decreased Serum Concentration of Total IgG Is Related to Tumor Progression in Gastric Cancer Patients.
June 2017, Yonago acta medica,
J Millán, and A Senra, and A Lorenzo, and J Romero, and P Rodriguez, and P Gallurt
[Biological characteristics of tumor progression].
January 1973, Voprosy onkologii,
J Millán, and A Senra, and A Lorenzo, and J Romero, and P Rodriguez, and P Gallurt
[Biological characteristics of tumor progression].
January 1977, Vestnik Akademii meditsinskikh nauk SSSR,
J Millán, and A Senra, and A Lorenzo, and J Romero, and P Rodriguez, and P Gallurt
Serum proteolytic activities and antiproteases in human colorectal carcinoma.
March 1998, Journal of physiology and biochemistry,
J Millán, and A Senra, and A Lorenzo, and J Romero, and P Rodriguez, and P Gallurt
Serum antiproteases and respiratory diseases of the horse.
January 1977, Folia veterinaria Latina,
J Millán, and A Senra, and A Lorenzo, and J Romero, and P Rodriguez, and P Gallurt
The onset and progression of atherosclerotic plaques as related to arterial wall changes.
January 1991, Romanian journal of internal medicine = Revue roumaine de medecine interne,
Copied contents to your clipboard!